Aurora Cannabis (NASDAQ: ACB) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.07) by 400 percent. This is a 45.83 percent decrease over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $61.842 million which beat the analyst consensus estimate of $55.290 million by 11.85 percent. This is a 1.95 percent decrease over sales of $63.070 million the same period last year.